Skip to main content
Tuesday, November 17, 2026Nov 17

South Korean firm’s $22 billion investment will mean new US jobs, White House says

President Joe Biden, on screen at left, listens as SK Group Chairman Chey Tae-won, right, speaks from the Roosevelt Room of the White House in Washington, Tuesday, July 26, 2022. The meeting comes as the Biden administration is seeking the cooperation of Asian allies such as South Korea to reinforce supply chains for critical components such as semiconductors. (AP Photo/Susan Walsh)
President Joe Biden, on screen at left, listens as SK Group Chairman Chey Tae-won, right, speaks from the Roosevelt Room of the White House in Washington, Tuesday, July 26, 2022. The meeting comes as the Biden administration is seeking the cooperation of Asian allies such as South Korea to reinforce supply chains for critical components such as semiconductors. (AP Photo/Susan Walsh)

WASHINGTON (AP) – South Korea’s SK Group on Tuesday announced plans to invest $22 billion in the United States on industries including semiconductors, green energy and bioscience, which the White House said will create tens of thousands of domestic jobs while helping ease global supply chain snarls that have persisted during the coronavirus pandemic.

President Joe Biden, who continues to isolate in the White House residence after testing positive for COVID-19 last week, met virtually with SK Group Chairman Chey Tae-won and called it a “historic and pathbreaking announcement.”

It is “proof that we’re meeting the emergency in the climate crisis with urgency and opportunity and innovation to save the planet and create good-paying jobs,” Biden said.

SK Group’s investments will include $15 billion in the semiconductor industry through research and development programs, as well as materials and a testing and packaging facility, which will help address supply chain problems, the conglomerate said in a statement.

Another $5 billion will go to green energy businesses, including electric vehicle charging stations, green hydrogen production and battery materials and recycling, SK Group said. The final batch, which the company described as worth “several billions of dollars,” would go toward biotechnologies developing new drugs designed to bolster competitiveness in the U.S. pharmaceutical industry.